Literature DB >> 16896162

Cellular localization of apelin and its receptor in the anterior pituitary: evidence for a direct stimulatory action of apelin on ACTH release.

Annabelle Reaux-Le Goazigo1, Rodrigo Alvear-Perez, Philippe Zizzari, Jacques Epelbaum, Marie-Thérèse Bluet-Pajot, Catherine Llorens-Cortes.   

Abstract

Apelin is a bioactive peptide recently identified as the endogenous ligand of the human orphan G protein-coupled receptor APJ. The presence of apelin-immunoreactive nerve fibers, together with the detection of apelin receptor mRNA in the parvocellular part of the paraventricular nucleus and the stimulatory action of apelin on corticotropin-releasing hormone release, indicate that apelin modulates adrenocorticotropin (ACTH) release via an indirect action on the hypothalamus. However, a direct action of apelin in the anterior pituitary cannot be excluded. Here, we provided evidence for the existence of an apelinergic system within the adult male rat pituitary gland. Double immunofluorescence staining indicated that apelin is highly coexpressed in the anterior pituitary, mainly in corticotrophs (96.5 +/- 0.3%) and to a much lower extent in somatotropes (3.2 +/- 0.2%). Using in situ hybridization combined with immunohistochemistry, a high expression of apelin receptor mRNA was also found in corticotrophs, suggesting a local interaction between apelin and ACTH. In an ex vivo perifusion system of anterior pituitaries, apelin 17 (K17F, 10(-6) M) significantly increased basal ACTH release by 41%, whereas apelin 10 (R10F, 10(-6) M), an inactive apelin fragment, was ineffective. In addition, K17F but not R10F induced a dose-dependent increase in K(+)-evoked ACTH release, with maximal increase being observed for a 10(-6) M concentration. Taken together, these data outline the potential role of apelin as an autocrine/paracrine-acting peptide on ACTH release and provide morphological and neuroendocrine basis for further studies that explore the physiological role of apelin in the regulation of anterior pituitary functions.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16896162     DOI: 10.1152/ajpendo.00521.2005

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  17 in total

Review 1.  Paracrinicity: the story of 30 years of cellular pituitary crosstalk.

Authors:  C Denef
Journal:  J Neuroendocrinol       Date:  2008-01       Impact factor: 3.627

Review 2.  Regulation of the Apelinergic System and Its Potential in Cardiovascular Disease: Peptides and Small Molecules as Tools for Discovery.

Authors:  Sanju Narayanan; Danni L Harris; Rangan Maitra; Scott P Runyon
Journal:  J Med Chem       Date:  2015-07-10       Impact factor: 7.446

3.  Apelin Receptor Signaling Protects GT1-7 GnRH Neurons Against Oxidative Stress In Vitro.

Authors:  Hatice Burcu Şişli; Taha Bartu Hayal; Selinay Şenkal; Binnur Kıratlı; Derya Sağraç; Selin Seçkin; Murat Özpolat; Fikrettin Şahin; Bayram Yılmaz; Ayşegül Doğan
Journal:  Cell Mol Neurobiol       Date:  2020-09-28       Impact factor: 5.046

4.  Increased bone mass in mice lacking the adipokine apelin.

Authors:  Lalita Wattanachanya; Wei-Dar Lu; Ramendra K Kundu; Liping Wang; Marcia J Abbott; Dylan O'Carroll; Thomas Quertermous; Robert A Nissenson
Journal:  Endocrinology       Date:  2013-04-12       Impact factor: 4.736

5.  Involvement of a Stat3 binding site in inflammation-induced enteric apelin expression.

Authors:  Song Han; Guiyun Wang; Xiang Qi; Ella W Englander; George H Greeley
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-09-25       Impact factor: 4.052

6.  Identification of potent pyrazole based APELIN receptor (APJ) agonists.

Authors:  Sanju Narayanan; Vineetha Vasukuttan; Sudarshan Rajagopal; Rangan Maitra; Scott P Runyon
Journal:  Bioorg Med Chem       Date:  2019-11-30       Impact factor: 3.641

Review 7.  International Union of Basic and Clinical Pharmacology. CVII. Structure and Pharmacology of the Apelin Receptor with a Recommendation that Elabela/Toddler Is a Second Endogenous Peptide Ligand.

Authors:  Cai Read; Duuamene Nyimanu; Thomas L Williams; David J Huggins; Petra Sulentic; Robyn G C Macrae; Peiran Yang; Robert C Glen; Janet J Maguire; Anthony P Davenport
Journal:  Pharmacol Rev       Date:  2019-10       Impact factor: 25.468

8.  The effects of apelin on the electrical activity of hypothalamic magnocellular vasopressin and oxytocin neurons and somatodendritic Peptide release.

Authors:  Vicky A Tobin; Philip M Bull; Sathya Arunachalam; Anne-Marie O'Carroll; Yoichi Ueta; Mike Ludwig
Journal:  Endocrinology       Date:  2008-08-14       Impact factor: 4.736

9.  Stress-dependent and gender-specific neuroregulatory roles of the apelin receptor in the hypothalamic-pituitary-adrenal axis response to acute stress.

Authors:  M J F Newson; G R Pope; E M Roberts; S J Lolait; A-M O'Carroll
Journal:  J Endocrinol       Date:  2013-01-02       Impact factor: 4.286

10.  The effects of apelin on hypothalamic-pituitary-adrenal axis neuroendocrine function are mediated through corticotrophin-releasing factor- and vasopressin-dependent mechanisms.

Authors:  Michael J F Newson; Emma M Roberts; George R Pope; Stephen J Lolait; Anne-Marie O'Carroll
Journal:  J Endocrinol       Date:  2009-04-24       Impact factor: 4.286

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.